Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

Bullboard Posts

Comment by Cryptobreakon Mar 18, 2020 10:03am

30 Views

Post# 30821066

RE:RE:RE:RE:RE:RE:RE:Website is up

Speaking of stock molestors.. Have a good look in the mirror, chances are you'll see the biggest one but then again if you can't see the value in VXL, you might see nothing but a normal idiot!

SmokedOut wrote:
Biggainer wrote: Wow? What's with the name calling.
I just clicked on the TSE website and also googled it.
Tough board.

Not tough. Just the usual pumper clowns getting nervous that yet another of their attempts to molest a stock isn't quite working out as planned. Don't take it personally.